QQQ   295.61 (-3.45%)
AAPL   142.91 (-4.24%)
MSFT   257.70 (-3.42%)
FB   195.98 (-3.28%)
GOOGL   2,262.93 (-2.86%)
AMZN   2,179.24 (-5.55%)
TSLA   727.95 (-4.42%)
NVDA   173.40 (-4.60%)
BABA   88.99 (-3.26%)
NIO   16.12 (-3.07%)
AMD   98.34 (-4.03%)
CGC   5.72 (-2.89%)
MU   71.51 (-3.99%)
T   20.44 (-0.63%)
GE   75.48 (-1.20%)
F   12.94 (-4.36%)
DIS   105.48 (-2.91%)
AMC   13.35 (+3.49%)
PFE   50.38 (-1.87%)
PYPL   78.13 (-2.03%)
NFLX   182.04 (-4.47%)
QQQ   295.61 (-3.45%)
AAPL   142.91 (-4.24%)
MSFT   257.70 (-3.42%)
FB   195.98 (-3.28%)
GOOGL   2,262.93 (-2.86%)
AMZN   2,179.24 (-5.55%)
TSLA   727.95 (-4.42%)
NVDA   173.40 (-4.60%)
BABA   88.99 (-3.26%)
NIO   16.12 (-3.07%)
AMD   98.34 (-4.03%)
CGC   5.72 (-2.89%)
MU   71.51 (-3.99%)
T   20.44 (-0.63%)
GE   75.48 (-1.20%)
F   12.94 (-4.36%)
DIS   105.48 (-2.91%)
AMC   13.35 (+3.49%)
PFE   50.38 (-1.87%)
PYPL   78.13 (-2.03%)
NFLX   182.04 (-4.47%)
QQQ   295.61 (-3.45%)
AAPL   142.91 (-4.24%)
MSFT   257.70 (-3.42%)
FB   195.98 (-3.28%)
GOOGL   2,262.93 (-2.86%)
AMZN   2,179.24 (-5.55%)
TSLA   727.95 (-4.42%)
NVDA   173.40 (-4.60%)
BABA   88.99 (-3.26%)
NIO   16.12 (-3.07%)
AMD   98.34 (-4.03%)
CGC   5.72 (-2.89%)
MU   71.51 (-3.99%)
T   20.44 (-0.63%)
GE   75.48 (-1.20%)
F   12.94 (-4.36%)
DIS   105.48 (-2.91%)
AMC   13.35 (+3.49%)
PFE   50.38 (-1.87%)
PYPL   78.13 (-2.03%)
NFLX   182.04 (-4.47%)
QQQ   295.61 (-3.45%)
AAPL   142.91 (-4.24%)
MSFT   257.70 (-3.42%)
FB   195.98 (-3.28%)
GOOGL   2,262.93 (-2.86%)
AMZN   2,179.24 (-5.55%)
TSLA   727.95 (-4.42%)
NVDA   173.40 (-4.60%)
BABA   88.99 (-3.26%)
NIO   16.12 (-3.07%)
AMD   98.34 (-4.03%)
CGC   5.72 (-2.89%)
MU   71.51 (-3.99%)
T   20.44 (-0.63%)
GE   75.48 (-1.20%)
F   12.94 (-4.36%)
DIS   105.48 (-2.91%)
AMC   13.35 (+3.49%)
PFE   50.38 (-1.87%)
PYPL   78.13 (-2.03%)
NFLX   182.04 (-4.47%)
OTCMKTS:INVVY

Indivior (INVVY) Stock Forecast, Price & News

$19.02
+0.57 (+3.09%)
(As of 05/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$18.77
$20.00
50-Day Range
$17.29
$22.58
52-Week Range
$10.00
$22.58
Volume
1,412 shs
Average Volume
2,165 shs
Market Capitalization
$2.68 billion
P/E Ratio
17.29
Dividend Yield
N/A
Beta
0.11
30 days | 90 days | 365 days | Advanced Chart
Receive INVVY News and Ratings via Email

Sign-up to receive the latest news and ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter.

Indivior logo

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Headlines

Indivior PLC (OTCMKTS:INVVY) Short Interest Update
See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:INVVY
Previous Symbol
NASDAQ:INVVY
CIK
N/A
Employees
800
Year Founded
N/A

Sales & Book Value

Annual Sales
$791 million
Cash Flow
$1.21 per share
Book Value
$1.45 per share

Profitability

Net Income
$205 million
Pretax Margin
24.02%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$2.68 billion
Optionable
Not Optionable

Company Calendar

Today
5/18/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.09 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -













Indivior (OTCMKTS:INVVY) Frequently Asked Questions

Is Indivior a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Indivior stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INVVY, but not buy additional shares or sell existing shares.
View analyst ratings for Indivior
or view top-rated stocks.

Are investors shorting Indivior?

Indivior saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 15,800 shares, an increase of 38.6% from the April 15th total of 11,400 shares. Based on an average daily trading volume, of 4,100 shares, the days-to-cover ratio is presently 3.9 days.
View Indivior's Short Interest
.

Who are Indivior's key executives?
Indivior's management team includes the following people:
  • Mr. Mark Crossley, CEO & Exec. Director
  • Mr. Ryan Preblick, CFO & Exec. Director
  • Dr. Christian Heidbreder, Chief Scientific Officer
  • Mr. Jason Thompson, VP of Investor Relations
  • Ms. Cynthia Cetani, Chief Integrity & Compliance Officer
  • Mr. Jeffrey W. Burris, Chief Legal Officer (Age 50)
  • Mr. Jon Fogle, Chief HR Officer
  • Mr. Richard Simkin, Chief Commercial & Strategy Officer
  • Mr. Hillel West, Chief Manufacturing & Supply Officer
  • Ms. Kathryn Hudson, Company Sec.
What is Indivior's stock symbol?

Indivior trades on the OTCMKTS under the ticker symbol "INVVY."

How do I buy shares of Indivior?

Shares of INVVY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Indivior's stock price today?

One share of INVVY stock can currently be purchased for approximately $19.02.

How much money does Indivior make?

Indivior has a market capitalization of $2.68 billion and generates $791 million in revenue each year. The company earns $205 million in net income (profit) each year or $1.10 on an earnings per share basis.

How many employees does Indivior have?

Indivior employs 800 workers across the globe.

What is Indivior's official website?

The official website for Indivior is www.indivior.com.

How can I contact Indivior?

Indivior's mailing address is 10710 Midlothian Turnpike, North Chesterfield VA, 23235. The company can be reached via phone at 804-379-1090, via email at [email protected], or via fax at 804-379-1215.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.